Institutional investors purchased a net $1.1 million shares of SCLN during the quarter ended September 2016. This may signal that the smart money is gaining interest in this company as the 76.26% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Other industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
EQIS CAPITAL MANAGEMENT, INC. Bought 33.7 Thousand shares of SciClone Pharmaceuticals ...